{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:49:12Z","timestamp":1789148952136,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003785","name":"Medical Scientific Research Foundation of Guangdong Province of China","doi-asserted-by":"crossref","award":["B2025689"],"award-info":[{"award-number":["B2025689"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFC2505106"],"award-info":[{"award-number":["2022YFC2505106"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key-Area Research and Development Program of Guangdong Province","award":["2019B020227004"],"award-info":[{"award-number":["2019B020227004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04615-0","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:45:14Z","timestamp":1765809914000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of metabolic syndrome and hyperuricemia with mortality in patients with chronic kidney disease: a UK biobank study"],"prefix":"10.1186","volume":"26","author":[{"given":"Chengkai","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"4615_CR1","doi-asserted-by":"publisher","unstructured":"Guo J, Liu Z, Wang P, Wu H, Fan K, Jin J, et al. Global, regional, and national burden inequality of chronic kidney disease, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Front Med. 2025;11:1501175. https:\/\/doi.org\/10.3389\/fmed.2024.1501175.","DOI":"10.3389\/fmed.2024.1501175"},{"issue":"10225","key":"4615_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and National burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709\u201333.","journal-title":"Lancet"},{"issue":"10302","key":"4615_CR3","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Preserving kidney function in people with chronic kidney disease. Lancet. 2021;398(10302):786\u2013802.","journal-title":"Lancet"},{"issue":"17","key":"4615_CR4","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. Circulation. 2005;112(17):2735\u201352.","journal-title":"Circulation"},{"issue":"24","key":"4615_CR5","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2020.4501","volume":"323","author":"G Hirode","year":"2020","unstructured":"Hirode G, Wong RJ. Trends in the prevalence of metabolic syndrome in the united States, 2011\u20132016. JAMA. 2020;323(24):2526\u20138.","journal-title":"JAMA"},{"issue":"2","key":"4615_CR6","first-page":"507","volume":"102","author":"J Lu","year":"2017","unstructured":"Lu J, Wang L, Li M, Xu Y, Jiang Y, Wang W, et al. Metabolic syndrome among adults in china: the 2010 China noncommunicable disease surveillance. J Clin Endocrinol Metabolism. 2017;102(2):507\u201315.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"3","key":"4615_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1053\/j.ajkd.2006.06.003","volume":"48","author":"T Ninomiya","year":"2006","unstructured":"Ninomiya T, Kiyohara Y, Kubo M, Yonemoto K, Tanizaki Y, Doi Y, et al. Metabolic syndrome and CKD in a general Japanese population: the Hisayama study. Am J Kidney Dis. 2006;48(3):383\u201391.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"4615_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","volume":"140","author":"J Chen","year":"2004","unstructured":"Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. Adults. Ann Intern Med. 2004;140(3):167\u201374.","journal-title":"Ann Intern Med"},{"issue":"12","key":"4615_CR9","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.3390\/biomedicines12122706","volume":"12","author":"KW Jang","year":"2024","unstructured":"Jang KW, Hur J, Lee DW, Kim SR. Metabolic Syndrome, kidney-Related Adiposity, and kidney microcirculation: unraveling the damage. Biomedicines. 2024;12(12):2706.","journal-title":"Biomedicines"},{"issue":"5","key":"4615_CR10","doi-asserted-by":"publisher","first-page":"e035614","DOI":"10.1136\/bmjopen-2019-035614","volume":"10","author":"B Han","year":"2020","unstructured":"Han B, Wang N, Chen Y, Li Q, Zhu C, Chen Y, et al. Prevalence of hyperuricaemia in an Eastern Chinese population: a cross-sectional study. BMJ Open. 2020;10(5):e035614.","journal-title":"BMJ Open"},{"issue":"34","key":"4615_CR11","doi-asserted-by":"publisher","first-page":"2404047","DOI":"10.1002\/advs.202404047","volume":"11","author":"L Zeng","year":"2024","unstructured":"Zeng L, Ma P, Li Z, Liang S, Wu C, Hong C, et al. Multimodal machine Learning-Based marker enables early detection and prognosis prediction for hyperuricemia. Adv Sci. 2024;11(34):2404047.","journal-title":"Adv Sci"},{"issue":"1","key":"4615_CR12","doi-asserted-by":"publisher","first-page":"7841","DOI":"10.1038\/s41598-020-64884-7","volume":"10","author":"N Ali","year":"2020","unstructured":"Ali N, Miah R, Hasan M, Barman Z, Mou AD, Hafsa JM, et al. Association between serum uric acid and metabolic syndrome: a cross-sectional study in Bangladeshi adults. Sci Rep. 2020;10(1):7841.","journal-title":"Sci Rep"},{"issue":"6","key":"4615_CR13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.metabol.2008.01.030","volume":"57","author":"X Sui","year":"2008","unstructured":"Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metabolism - Clin Experimental. 2008;57(6):845\u201352.","journal-title":"Metabolism - Clin Experimental"},{"key":"4615_CR14","doi-asserted-by":"publisher","first-page":"1403858","DOI":"10.3389\/fendo.2024.1403858","volume":"15","author":"R Gou","year":"2024","unstructured":"Gou R, Dou D, Tian M, Chang X, Zhao Y, Meng X, et al. Association between triglyceride glucose index and hyperuricemia: a new evidence from China and the united States. Front Endocrinol (Lausanne). 2024;15:1403858.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4615_CR15","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.2147\/DMSO.S483497","volume":"17","author":"J Wu","year":"2024","unstructured":"Wu J, Lin X, Yin X, Xu Z, Wu N, Zhang Z, et al. Comparison of incidence of metabolic syndrome and five Obesity- and Lipid-Linked indicators for predicting metabolic syndrome among Normal-Weight and overweight adults. DMSO. 2024;17:3509\u201320.","journal-title":"DMSO"},{"issue":"17","key":"4615_CR16","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.3390\/ijms22179221","volume":"22","author":"H Yanai","year":"2021","unstructured":"Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular biological and clinical Understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic Syndrome, cardiovascular diseases and chronic kidney disease. Int J Mol Sci. 2021;22(17):9221.","journal-title":"Int J Mol Sci"},{"key":"4615_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejim.2022.04.022","volume":"103","author":"S Copur","year":"2022","unstructured":"Copur S, Demiray A, Kanbay M. Uric acid in metabolic syndrome: does uric acid have a definitive role? Eur J Intern Med. 2022;103:4\u201312.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"4615_CR18","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. https:\/\/doi.org\/10.1371\/journal.pmed.1001779.","journal-title":"PLoS Med"},{"key":"4615_CR19","doi-asserted-by":"publisher","unstructured":"Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C\u2013based equations to estimate GFR without race. New Engl J Med Published Online November. 2021;4. https:\/\/doi.org\/10.1056\/NEJMoa2102953.","DOI":"10.1056\/NEJMoa2102953"},{"issue":"4","key":"4615_CR20","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J, et al. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100(4):S1\u2013276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021.","journal-title":"Kidney Int"},{"issue":"1","key":"4615_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01916-y","volume":"9","author":"L Du","year":"2024","unstructured":"Du L, Zong Y, Li H, Wang Q, Xie L, Yang B, et al. Hyperuricemia and its related diseases: mechanisms and advances in therapy. Sig Transduct Target Ther. 2024;9(1):1\u201329.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"4615_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-024-00563-5","volume":"10","author":"IJ Neeland","year":"2024","unstructured":"Neeland IJ, Lim S, Tchernof A, Gastaldelli A, Rangaswami J, Ndumele CE, et al. Metabolic syndrome. Nat Rev Dis Primers. 2024;10(1):1\u201322.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"4615_CR23","doi-asserted-by":"publisher","first-page":"e0162388","DOI":"10.1371\/journal.pone.0162388","volume":"11","author":"SV Eastwood","year":"2016","unstructured":"Eastwood SV, Mathur R, Atkinson M, et al. Algorithms for the capture and adjudication of prevalent and incident diabetes in UK biobank. PLoS ONE. 2016;11(9):e0162388. https:\/\/doi.org\/10.1371\/journal.pone.0162388.","journal-title":"PLoS ONE"},{"issue":"2","key":"4615_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2337\/dc21-1512","volume":"45","author":"H Han","year":"2022","unstructured":"Han H, Cao Y, Feng C, Zheng Y, Dhana K, Zhu S, et al. Association of a healthy lifestyle with All-Cause and Cause-Specific mortality among individuals with type 2 diabetes: A prospective study in UK biobank. Diabetes Care. 2022;45(2):319\u201329.","journal-title":"Diabetes Care"},{"issue":"4","key":"4615_CR25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/2211-5463.12400","volume":"8","author":"A Mima","year":"2018","unstructured":"Mima A, Yasuzawa T, King GL, Ueshima S. Obesity-associated glomerular inflammation increases albuminuria without renal histological changes. FEBS Open Bio. 2018;8(4):664\u201370.","journal-title":"FEBS Open Bio"},{"issue":"6","key":"4615_CR26","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/joim.13355","volume":"290","author":"LM Pammer","year":"2021","unstructured":"Pammer LM, Lamina C, Schultheiss UT, Kotsis F, Kollerits B, Stockmann H, et al. Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort. J Intern Med. 2021;290(6):1219\u201332.","journal-title":"J Intern Med"},{"issue":"12","key":"4615_CR27","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s11255-018-1934-6","volume":"50","author":"A Ma","year":"2018","unstructured":"Ma A, Liu F, Wang C, Liang K, Yan F, Hou X, et al. Both insulin resistance and metabolic syndrome accelerate the progression of chronic kidney disease among Chinese adults: results from a 3-year follow-up study. Int Urol Nephrol. 2018;50(12):2239\u201344.","journal-title":"Int Urol Nephrol"},{"issue":"8","key":"4615_CR28","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.metabol.2013.02.009","volume":"62","author":"P Kangas","year":"2013","unstructured":"Kangas P, Tikkakoski AJ, Tahvanainen AM, Leskinen MH, Viitala JM, K\u00e4h\u00f6nen M, et al. Metabolic syndrome May be associated with increased arterial stiffness even in the absence of hypertension: A study in 84 cases and 82 controls. Metabolism - Clin Experimental. 2013;62(8):1114\u201322.","journal-title":"Metabolism - Clin Experimental"},{"issue":"5","key":"4615_CR29","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/HJH.0b013e3280a94e76","volume":"25","author":"I Ferreira","year":"2007","unstructured":"Ferreira I, Boreham CA, Twisk JWR, Gallagher AM, Young IS, Murray LJ, et al. Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: the Northern Ireland young hearts project. J Hypertens. 2007;25(5):1009\u201320.","journal-title":"J Hypertens"},{"issue":"2","key":"4615_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.ajkd.2007.05.013","volume":"50","author":"M Chonchol","year":"2007","unstructured":"Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, et al. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis. 2007;50(2):239\u201347.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"4615_CR31","first-page":"E107","volume":"64","author":"A HARYONO","year":"2018","unstructured":"HARYONO A, NUGRAHANINGSIH DAA, SARI DCR, ROMI MM. Reduction of serum uric acid associated with Attenuation of renal Injury, inflammation and macrophages M1\/M2 ratio in hyperuricemic mice model. Kobe J Med Sci. 2018;64(3):E107\u201314.","journal-title":"Kobe J Med Sci"},{"issue":"6","key":"4615_CR32","doi-asserted-by":"publisher","first-page":"e39738","DOI":"10.1371\/journal.pone.0039738","volume":"7","author":"Y Zhou","year":"2012","unstructured":"Zhou Y, Fang L, Jiang L, Wen P, Cao H, He W, et al. Uric acid induces renal inflammation via activating tubular NF-\u03baB signaling pathway. PLoS ONE. 2012;7(6):e39738.","journal-title":"PLoS ONE"},{"issue":"2","key":"4615_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.nefroe.2022.04.005","volume":"43","author":"PR Bignardi","year":"2023","unstructured":"Bignardi PR, Ido DH, Garcia FAL, Braga LM, Delfino VDA. Does uric acid-lowering treatment slow the progression of chronic kidney disease? A meta-analysis of randomized controlled trials. Nefrolog\u00eda (English Edition). 2023;43(2):167\u201381.","journal-title":"Nefrolog\u00eda (English Edition)"},{"issue":"6","key":"4615_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11906-024-01295-3","volume":"26","author":"R Vareldzis","year":"2024","unstructured":"Vareldzis R, Perez A, Reisin E. Hyperuricemia: an intriguing connection to metabolic Syndrome, Diabetes, kidney Disease, and hypertension. Curr Hypertens Rep. 2024;26(6):237\u201345.","journal-title":"Curr Hypertens Rep"},{"issue":"9","key":"4615_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11906-017-0770-x","volume":"19","author":"I Mortada","year":"2017","unstructured":"Mortada I, Hyperuricemia. Type 2 diabetes Mellitus, and hypertension: an emerging association. Curr Hypertens Rep. 2017;19(9):69.","journal-title":"Curr Hypertens Rep"},{"issue":"10","key":"4615_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11906-016-0684-z","volume":"18","author":"SG Mallat","year":"2016","unstructured":"Mallat SG, Al Kattar S, Tanios BY, Jurjus A. Hyperuricemia, Hypertension, and chronic kidney disease: an emerging association. Curr Hypertens Rep. 2016;18(10):74.","journal-title":"Curr Hypertens Rep"},{"key":"4615_CR37","doi-asserted-by":"publisher","unstructured":"Chen XY, Lu F, Zhang J, Xu CX, Du XF, Liang MB, et al. The effect of hyperuricemia and its interaction with hypertension towards chronic kidney disease in patients with type 2 diabetes: evidence from a cross-sectional study in Eastern China. Front Endocrinol. 2024;15:1415459. https:\/\/doi.org\/10.3389\/fendo.2024.1415459.","DOI":"10.3389\/fendo.2024.1415459"},{"issue":"5","key":"4615_CR38","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.105.579342","volume":"113","author":"T Willum-Hansen","year":"2006","unstructured":"Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113(5):664\u201370.","journal-title":"Circulation"},{"key":"4615_CR39","unstructured":"Cardiovascular-Kidney-Metabolic Health: a presidential advisory from the American Heart Association | Circulation. Accessed August 24. 2025. https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000001184."},{"issue":"1","key":"4615_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12872-025-04910-6","volume":"25","author":"S Zhao","year":"2025","unstructured":"Zhao S, Liu H, Liu A. Associations of cardiovascular-kidney-metabolic conditions with all-cause and cardiovascular mortality among US adults: a population-based cohort study. BMC Cardiovasc Disord. 2025;25(1):443. https:\/\/doi.org\/10.1186\/s12872-025-04910-6.","journal-title":"BMC Cardiovasc Disord"},{"key":"4615_CR41","doi-asserted-by":"publisher","first-page":"100985","DOI":"10.1016\/j.ajpc.2025.100985","volume":"22","author":"J Li","year":"2025","unstructured":"Li J, Wei X. Association of cardiovascular-kidney-metabolic syndrome with all-cause and cardiovascular mortality: A prospective cohort study. Am J Prev Cardiol. 2025;22:100985. https:\/\/doi.org\/10.1016\/j.ajpc.2025.100985.","journal-title":"Am J Prev Cardiol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04615-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04615-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04615-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:45:18Z","timestamp":1765809918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04615-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4615"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04615-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for UKBB data collection was granted by the NHS National Research Ethics Committee (no: 16\/NW\/0274). All research procedures were conducted in strict compliance with the Declaration of Helsinki principles, and written informed consent was obtained from every participant prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"696"}}